These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25807276)

  • 1. Analysis of pharmacogenomic variants associated with population differentiation.
    Yeon B; Ahn E; Kim KI; Kim IW; Oh JM; Park T
    PLoS One; 2015; 10(3):e0119994. PubMed ID: 25807276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.
    Ahn E; Park T
    Sci Rep; 2017 Sep; 7(1):8416. PubMed ID: 28871186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.
    Wang L; Aikemu A; Yibulayin A; Du S; Geng T; Wang B; Zhang Y; Jin T; Yang J
    BMC Genet; 2015 Jun; 16():66. PubMed ID: 26091847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
    Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
    Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
    He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
    Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
    Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
    Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.
    Jin T; Aikemu A; Zhang M; Geng T; Feng T; Kang L; Luo ML
    Med Sci Monit; 2015 Dec; 21():3769-76. PubMed ID: 26632549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limits of genome-wide methods for pharmacogenomic testing.
    Gamazon ER; Skol AD; Perera MA
    Pharmacogenet Genomics; 2012 Apr; 22(4):261-72. PubMed ID: 22344246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
    Li D; Peng L; Xing S; He C; Jin T
    BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global spectrum of protein-coding pharmacogenomic diversity.
    Wright GEB; Carleton B; Hayden MR; Ross CJD
    Pharmacogenomics J; 2018 Jan; 18(1):187-195. PubMed ID: 27779249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PharmGKB: the Pharmacogenetics Knowledge Base.
    Hewett M; Oliver DE; Rubin DL; Easton KL; Stuart JM; Altman RB; Klein TE
    Nucleic Acids Res; 2002 Jan; 30(1):163-5. PubMed ID: 11752281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
    Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
    Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ancestry plays a central role in population pharmacogenomics.
    Yang HC; Chen CW; Lin YT; Chu SK
    Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.
    Choi J; Tantisira KG; Duan QL
    Pharmacogenomics J; 2019 Apr; 19(2):127-135. PubMed ID: 30214008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FstSNP-HapMap3: a database of SNPs with high population differentiation for HapMap3.
    Duan S; Zhang W; Cox NJ; Dolan ME
    Bioinformation; 2008; 3(3):139-41. PubMed ID: 19238253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pharmacogenomic very important pharmacogenomic variants:
    Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B
    Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384
    [No Abstract]   [Full Text] [Related]  

  • 20. PharmGKB: understanding the effects of individual genetic variants.
    Sangkuhl K; Berlin DS; Altman RB; Klein TE
    Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.